Saturday, 8 May 2021 - 26 of Iyyar, 5781

French magazine devotes cover story to ‘post-COVID’ Israel

Google+ Pinterest LinkedIn Tumblr +

‘Le Parisien’ reports that “Tel Aviv is no longer hiding its face behind a mask.”

By Neta Bar, Israel Hayom via JNS

Israel’s success in beating back the COVID pandemic continues to attract attention in international media outlets, and this weekend, the French magazine Le Parisien devoted a cover story to Israel as an example of life “after” COVID.

The feature article, which interviews numerous Israelis and includes colorful descriptions of a busy Tel Aviv and Israel’s unprecedented national vaccination operation, is titled “A Taste of Life After [COVID].”

“Tel Aviv is no longer hiding its face behind a mask. It is now open to the air and to people on the street, even though sometimes a mask hides under a chin,” the article informs readers.

The article attributes Israel’s success to its digitized healthcare system, the relative discipline of its population, and efforts by Israeli Prime Minister Benjamin Netanyahu, who the magazine said “Fought tooth and nail for the vaccines … harassing the Pfizer CEO 30 times with phone conversations into the night.”

A separate article posted on the magazine’s website reported that Israel had marked the first day in months without a single COVID fatality, and said that since January, Israel had the lowest percentage of serious COVID cases in the world.

Israel still ahead in vaccination roll-out

Israel has been the leader in vaccination in the world since the very beginning and is still firmly in the lead. More than 10 million doses have now been injected, or 120 per 100 inhabitants.

The United Arab Emirates are in second place with just over 100 doses administered per 100 inhabitants. Next in line are Chile (73 per 100 inhabitants), which only started at the beginning of February, and the island of Malta (70).

The United States is in 7th place, with 67 vaccinations per 100 inhabitants.

EJP contributed to this report.


About Author

Leave A Reply